Go Pro

Attovia Therapeutics (ATTO) Earnings Date, Estimates & Call Transcripts

$17.78 -0.39 (-2.15%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$17.80 +0.02 (+0.08%)
As of 09/25/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Attovia Therapeutics Earnings Summary

Attovia Therapeutics issued Q2 2026 earnings on September 2, 2026, reporting an EPS of -$4.88. Quarterly revenue was reported to be $0.45 million. With a trailing EPS of $0.00, Attovia Therapeutics' earnings are expected to grow next year, from ($4.06) to ($2.38) per share.

Actual Revenue
(Sep. 2)
$0.45M

Q2 2026 Earnings Resources

Get Attovia Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Attovia Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Attovia Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($4.06) EPS
Next Year EPS Consensus Estimate
($2.38) EPS

Attovia Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/2/2026Q2 2026--$4.88--$4.88-$0.45M

Attovia Therapeutics Earnings - Frequently Asked Questions

Attovia Therapeutics (NASDAQ:ATTO) last announced its quarterly earning data on Wednesday, September 2, 2026. Learn more on ATTO's earnings history.

Attovia Therapeutics' earnings are expected to grow from ($4.06) per share to ($2.38) per share in the next year.


Earnings data for NASDAQ:ATTO is sourced from Fiscal.ai, with the most recent quarter reported on 9/2/2026. New results are added as companies report their earnings.
From Our Partners